• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Owlet Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    10/22/25 6:38:14 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials
    Get the next $OWLT alert in real time by email
    owlt-20251021
    0001816708FALSE00018167082025-10-212025-10-21

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    PURSUANT TO SECTION 13 OR 15(d)
    OF THE SECURITIES EXCHANGE ACT OF 1934
    Date of Report (Date of earliest event reported): October 21, 2025
    OWLET, INC.
    (Exact name of registrant as specified in its charter)
    Owlet Logomark (JPG).jpg
    Delaware001-3951685-1615012
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (I.R.S. Employer
    Identification No.)
    2940 West Maple Loop Drive Suite 203
    Lehi, Utah
    84048
    (Address of principal executive offices)(Zip Code)
    (844) 334-5330
    (Registrant’s telephone number, including area code)
    N/A
    (Former name or former address, if changed since last report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading
    Symbol(s)
    Name of each exchange
    on which registered
    Class A Common Stock, $0.0001 par value per share
    OWLTNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☒
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



    Item 2.02. Other Events. Results of Operations and Financial Condition.
    On October 21, 2025, Owlet, Inc. (the “Company”) disclosed in a preliminary prospectus supplement related to the Offering (as defined below) certain preliminary unaudited financial results for the three months ended September 30, 2025 and as of September 30, 2025 including that:
    •Revenue for the three months ended September 30, 2025 is estimated to be $30 million to $32 million, compared to $22.1 million for the corresponding period of 2024.
    •Gross margin for the three months ended September 30, 2025 is estimated to be approximately 49.5%-51%, compared to 52.2% for the corresponding period of 2024, a decrease the Company believes is primarily attributable to the impact of tariffs on its cost of goods sold.
    •Cash and cash equivalents as of September 30, 2025 are estimated to be approximately $23.8 million, which includes approximately $18.6 million in additional borrowings during the three months ended September 30, 2025 under the Company’s asset-based revolving credit facility.
    The preliminary unaudited third quarter 2025 financial results (the "preliminary financial information") are preliminary and were prepared by the Company’s management, based upon its estimates, a number of assumptions and currently available information, and are subject to revision based upon, among other things, quarter-end closing procedures and/or adjustments, the completion of the Company’s interim financial statements and other operational procedures. This preliminary financial information is the responsibility the Company’s management and has been prepared in good faith on a consistent basis with prior periods. However, the Company has not completed its financial closing procedures for the three months ended September 30, 2025, and the Company’s actual results could be materially different from the preliminary financial information provided above. The Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP, has not audited, reviewed, examined, compiled nor applied agreed-upon procedures with respect to the accompanying preliminary financial information and, accordingly, PricewaterhouseCoopers LLP does not express an opinion or any other form of assurance with respect thereto. The PricewaterhouseCoopers LLP report included in the Company’s annual report on Form 10-K for the year ended December 31, 2024 relates to the Company's previously issued financial statements. It does not extend to the preliminary financial information and should not be read to do so.
    During the course of the preparation of the Company’s financial statements and related notes as of and for the three and nine months ended September 30, 2025, the Company may identify items that would require it to make material adjustments to this preliminary financial information. As a result, prospective investors should exercise caution in relying on this information and should not draw any inferences from this information. This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with United States generally accepted accounting principles and reviewed by PricewaterhouseCoopers LLP.
    The Company is furnishing the information contained in Item 2.02 of this report pursuant to Item 2.02 of Form 8-K promulgated by the Securities and Exchange Commission (the “Commission”). Such information shall not be deemed to be “filed” with the Commission for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing.
    Item 8.01. Other Events.
    On October 21, 2025, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with William Blair & Company, L.L.C. and TD Securities (USA) LLC, as representatives (the “Representatives”) of the several underwriters named in Schedule A thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell 4,196,000 shares (the “Shares”) of its Class A common stock, par value $0.0001 per share (“Common Stock”), at a price to the public of $7.15 per Share, less underwriting discounts and commissions (the “Offering”). In addition, under the terms of the Underwriting Agreement, the Company granted the Underwriters the option, for 30 days, to purchase up to 629,400 additional shares of Common Stock at the public offering price per



    share, less underwriting discounts and commissions. The Company intends to use the net proceeds of the Offering to support continued commercialization and research and development, and for general corporate purposes.
    The Shares are being offered pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-281556), filed by the Company with the Commission on August 14, 2024. A final prospectus relating to the Offering was filed with the Commission on October 22, 2025 (the “Prospectus”).
    The Company and the Company’s directors and executive officers and certain stockholders also agreed not to sell or transfer any Common Stock without first obtaining the written consent of the Representatives, subject to certain exceptions as described in the Prospectus, for 90 days after the date of the Prospectus.
    The Underwriting Agreement contains customary representations, warranties, covenants, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act and other obligations of the parties. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. A copy of the Underwriting Agreement is attached as Exhibit 1.1 hereto and is incorporated herein by reference. The foregoing descriptions of the Underwriting Agreement and lock-up arrangements do not purport to be complete and are qualified in their entirety by reference to such exhibit.
    A copy of the opinion of Potter Anderson & Corroon LLP relating to the validity of the securities issued in the Offering is filed herewith as Exhibit 5.1.
    Item 9.01. Financial Statements and Exhibits.
    Exhibit No.Exhibit Description
    1.1
    Underwriting Agreement, dated as of October 21, 2025, by and among Owlet, Inc., William Blair & Company, L.L.C., TD Securities (USA) LLC and the several underwriters named therein.
    5.1
    Opinion of Potter Anderson & Corroon LLP.
    23.1
    Opinion of Potter Anderson & Corroon LLP (included in Exhibit 5.1).
    104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).



    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    OWLET, INC.
    Date: October 22, 2025
    /s/ Amanda Crawford
    Amanda Crawford
    Chief Financial Officer

    Get the next $OWLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OWLT

    DatePrice TargetRatingAnalyst
    4/23/2025$7.00Outperform
    Northland Capital
    10/6/2021$12.00 → $5.00Neutral
    Citigroup
    10/5/2021$8.50 → $5.50Buy → Neutral
    BofA Securities
    9/8/2021$8.50Buy
    BofA Securities
    8/5/2021$11.00Neutral
    Citigroup
    More analyst ratings

    $OWLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Owlet with a new price target

    Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00

    4/23/25 9:11:45 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Citigroup reiterated coverage on Owlet with a new price target

    Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously

    10/6/21 12:45:24 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet downgraded by BofA Securities with a new price target

    BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously

    10/5/21 7:41:47 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    SEC Filings

    View All

    SEC Form S-3 filed by Owlet Inc.

    S-3 - Owlet, Inc. (0001816708) (Filer)

    11/21/25 4:04:33 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form S-8 filed by Owlet Inc.

    S-8 - Owlet, Inc. (0001816708) (Filer)

    11/14/25 4:35:12 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Owlet Inc.

    10-Q - Owlet, Inc. (0001816708) (Filer)

    11/13/25 4:34:08 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Owlet and Locus Health Partner to Seamlessly Deliver Infant Health Data into Remote Patient Monitoring Programs

    This first-of-its-kind infant care collaboration for Owlet enables clinicians to access Owlet's data through Locus Health's platform, enhancing visibility, improving care continuity, and supporting families after hospital discharge. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Locus Health, a leader in remote patient monitoring, for more integrated infant health management. The collaboration connects data from Owlet's FDA-cleared prescription device, BabySat®, directly into the Locus Health platform, giving healthcare providers ongoing and secure access to vital infant health information after hospital disch

    11/19/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Third Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of

    11/13/25 4:16:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Partners with Rhapsody to Connect Remote Baby Monitoring Data to EHRs

    Collaboration bridges home and hospital, creating a secure pathway for pediatric insights to be managed and shared. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces a partnership with Rhapsody, a global leader in digital health enablement and interoperability, to securely connect infant health insights from Owlet's FDA-cleared, prescription pulse oximeter, BabySat®, directly into their existing electronic health record (EHR) workflows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112744527/en/Owlet partners with Rhapsody to securely connect infant vital signs from

    11/12/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Workman Kurt was granted 80,235 shares, increasing direct ownership by 24% to 419,004 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:14:01 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Director Kim John C. was granted 107,626 shares, increasing direct ownership by 86% to 233,030 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:13:31 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Large owner Trilogy Equity Partners, Llc converted options into 686,469 shares, increasing direct ownership by 78% to 1,567,468 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    10/15/25 9:12:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Owlet Inc.

    SC 13G/A - Owlet, Inc. (0001816708) (Subject)

    10/24/24 4:05:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 6:39:55 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 4:25:26 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Leadership Updates

    Live Leadership Updates

    View All

    Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m

    10/2/23 8:30:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome

    8/16/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

    Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'

    7/19/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Financials

    Live finance-specific insights

    View All

    Owlet Reports Third Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the third quarter ended September 30, 2025. Owlet's Chief Executive Officer and President, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, November 13, 2025, at 4:30 p.m. ET. Q3 2025 Financial Highlights: Record Q3 Revenue of $32.0 million, up 44.6% from Q3 2024 Record Q3 Gross Profit of $16.2 million; Q3 Gross Margin of 50.6%, down 150 basis points from Q3 2024 driven primarily by tariff impact Record Q3 Operating Income of

    11/13/25 4:16:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 646-844-6383 (international) and reference Access Code 428622. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay w

    10/29/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials